CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium® ( DrugBank: Titanium )


1 disease
IDDisease name (Link within this page)Number of trials
70Spinal stenosis1

70. Spinal stenosis


Clinical trials : 96 Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05023733
(ClinicalTrials.gov)
October 1, 202116/8/2021Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular ImplantClinical and Radiographic Outcomes of Transforaminal Lumbar Interbody Fusion (TLIF) With a Novel 3D Printed Cellular Titanium ImplantForaminal Stenosis;Degenerative Disc Disease;Lumbar Spondylolisthesis;Lumbar Spinal StenosisDevice: CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium®Farhan KarimDePuy SynthesNot yet recruiting35 Years80 YearsAll150United States